Turing CEO: Probe makes 'mountain out of molehill'
November 04, 2015 at 16:37 PM EST
The Turing Pharmaceuticals CEO says that the price increase of the drug Daraprim won't affect overall prescription cost trends in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.